{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:10918",
      "entity_text" : "carnitine",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:4746",
      "entity_text" : "Perhexiline",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Perhexiline, which blocks carnitine palmitoyltransferase-1, is another agent not approved in the U.S., whose use may be limited by neuropathy; it improved EF and maximal oxygen consumption in individuals with CHF.",
  "reading_complete" : "2020-07-28T17:24:55Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:22:27Z",
  "trigger" : "blocks",
  "evidence" : [ "Perhexiline, which blocks carnitine" ],
  "pmc_id" : "6898975",
  "score" : 0
}